Skip to main content

BIOX · Bioceres Crop Solutions Corp. · Documents

Track BIOX — free
$0.21 -0.01 (-5.41%) At close · Nov 13 Play latest call Q4 2026 earnings call transcript
Market Cap
$13.40M
Shares
63.82M
Volume · Nov 13 85.89K Avg daily vol (3M) 311.99K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2026 Revenue $238.28M down 17.7% 20-F filed Oct 30, 2026 Earnings call Q4 2026 earnings call Held Sep 15, 2026
2026
Oct 30
Annual report 20-F FY2026, ended Jun 30
Pro Farm foreclosure drives $181.5 million loss

Bioceres Crop Solutions Corp. reported a $181.5 million loss from discontinued operations for the year ended June 30, 2026, compared with US$9.7 million in 2025, primarily driven by the Pro Farm Foreclosure.

Revenue $238.28M ▼ 17.7% Net loss $263.94M Diluted EPS -$4.06
Read from the MD&A section
2 source passages
The loss from discontinued operations for the year ended June 30, 2026 totaled $181.5 million compared to a loss of US$9.7 million in the year ended June 30, 2025. The increase of US$171.8 million was primarily driven by the Pro Farm Foreclosure. Open the document at this passage
Sep 21
Current report 6-K
Current report

Bioceres Crop Solutions Corp. says the New York Supreme Court granted plaintiffs’ damages motion, awarding amounts sought, per diem interest from July 23, 2026 until judgment, and $1.4 million in costs and attorneys’ fees; defendants plan to appeal.

2025
Nov 10
Annual report 20-F FY2025, ended Jun 30
Annual report for FY2025
Revenue $335.11M ▼ 27.9% Net loss $55.42M Diluted EPS -$0.88
2024
Oct 30
Annual report 20-F FY2024, ended Jun 30
Annual report for FY2024
Revenue $464.78M ▲ 10.6% Net income $3.24M ▼ 82.7% Diluted EPS $0.05 ▼ 82.8%
Showing 1–50 of 153 documents
Key facts CIK 1769484 CUSIP G1117K114 13F (30d) 33 filings 19 filers Visit website Investor relations